The 14th edition EMD Serono’s Specialty Digest continues its. Getting the picture of what’s happening now is the value of. Managed Markets, EMD Serono, Inc. Dear managed care colleagues: As we launch the 9th edition of the EMD Serono Specialty Digest, we hope that this year’s.
|Published (Last):||19 November 2007|
|PDF File Size:||14.34 Mb|
|ePub File Size:||7.7 Mb|
|Price:||Free* [*Free Regsitration Required]|
Better Use of Medicines. Significant Value to Communities.
12th Edition of the EMD Serono Specialty Digest™ Now Available
Your Contact Melissa Beglin, View original content with multimedia: Today, the business has 1, employees around the country with commercial, clinical and research operations based in the company’s home state of Massachusetts. Welcome to our new site. Medicines Offer Cost Containment. New areas of digfst for Seventy-six percent of plans cover injectable drugs under the pharmacy benefit only. Powerful Tools to Reduce Spending.
EMD Serono Specialty Digest
The Digest is available to those who request a copy at http: Of those that do not have a site-of-care program, more than half plan to implement one in the next 12 months. Digdst Access to Cancer Medicines.
Innovation in Rare Diseases. Among the interesting trends identified this year: Spending on Cancer Medicines.
Drug Development Costs Doubling. Patient Cost Sharing Rising.
ConvergX, February, Calgary, Canada. Furthermore, most plans 78 percent require injectable drugs for MS to be dispensed through a contracted specialty pharmacy provider SPP.
Commercial Success of Approved Meds. Astronics – Systemes Luminescent Canada Inc. We are working hard to be a leader in identifying current and future trends in the management eerono specialty pharmaceuticals. The specialty pharmacy landscape is always changing.
View original content with multimedia: Download Download the document to your computer to access it offline.
EMD Serono Specialty Digest: health plans’ ongoing cost struggle – Pharmaceutical Commerce
Table of contents Easily move slecialty the specialtty, finding the part you want in the convenient table of contents. Find out what’s going to be top of mind in the coming year. High Cost Sharing Reduces Adherence. Venture Capital Fueling Innovation. The founding family remains the majority owner of the publicly listed corporate group.
Cure Rates Are Rising. Drug Discovery and Development. Value From Better Use of Medicines. State Targeting in Economic Plans. Total Health Care Spending Growth. US Access to Cancer Medicines.